Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Upside Health Advisors is a private U.S. healthcare advisory and consulting firm focused on the health services market rather than drug development. The firm advises payers, providers, health systems, employers, health-tech companies, and investors on areas including value-based care, payment reform, fiduciary health services procurement, health policy, and compliance with the Consolidated Appropriations Act of 2021. It appears to be led by industry veterans Jeffrey Hogan and Christine Arnold and operates as a small, active consultancy with a national client focus. The company does not appear to have a therapeutic pipeline or proprietary drug platform; its core business is strategic advisory, due diligence, and market navigation across healthcare services and benefits ecosystems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Upside Health Advisors.